|Day Low/High||58.94 / 60.61|
|52 Wk Low/High||44.33 / 71.38|
This is new doctrine having to do with innovation and the stifling of innovation to create new products.
Regulatory issues will weigh on this deal, because of populist politics.
Prospective deals are hijacking an earnings-based focus on fundamentals.
For starters, trouble for banks, drugs, energy and M&A.
Dow Chemical rose more than 10% Monday after EU officials resumed their investigation into the company's proposed $130 million merger with DuPont.
Staying real, being transparent and honest. I made an important tactical move this afternoon -- close to the day's low. Talking Deutsche Bank in my Diary and in Barron's, I expect a capital raise (possibly rights offering, after a DOJ settlement). ...
Tesla shares rise after the company reports a record number of quarterly deliveries.
I suspect DuPont shares will trade a bit better in the near term after news that a timetable has been established in the restart of the European Union review of its planned merger with Dow Chemical . DuPont remains my favorite large-capitalization l...
Jim Cramer is skeptical the Dow Chemical merger with DuPont will be approved by regulators.
Dow Chemical and Dupont's proposed merger could face regulatory hurdles in Europe as regulators paused their review of the deal due to insufficient information provided by the companies.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.
The proposed merger between Dow Chemical and DuPont could be in jeopardy.
Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.
Bloomberg Radio, listen! Bloomberg TV, watch! I have a crush on Twitter . Why the rally in retail may not be justified. Parts one and two and three. I am a buyer of Macy's down 10% (or so) from here. I initiated a small J.C. Penney long. I add...
Second quarter earnings have been mixed so far, according to Jim Cramer.
A solid second quarter had Dow Chemical shares on the rise Thursday.
Another heavy day on the earnings front kept investors busy.
It's unclear if the Dow Chemical and Dupont merger will take place, according to TheStreet's Jim Cramer.
Facebook crushes earnings expectations while SABMiller puts a hold on the AB InBev deal.
Good enough, tied with a good story, is pushing post-earnings bumps today.
DuPont shares were on the rise Tuesday following its latest quarterly results.
U.S. stocks recovered from a two-day selloff on Tuesday as the shock of the Brexit vote faded and hopes of further stimulus rose.
The materials sector has been one of the S&P's leaders so far in 2016 with returns trailing only utilities and energy.
Without it, any rally would just be a short-covering bump.
I started the day with Apple (AAPL) as JPMorgan reduced the share price target from $125 to $105. Then a sports metaphor and an interesting two-part opening missive on the markets -- here and here. I got lucky and covered a bunch into the mornin...